Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06209866
Other study ID # Glass Stage and WIFI Stage
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2024
Est. completion date February 1, 2026

Study information

Verified date January 2024
Source Assiut University
Contact Mohamed Ahmed Mohamed, Resident
Phone 01028524010
Email mohamedbashandy20@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

compare between GLASS and WIFI Staging in predicting limb salvage in patients with chronic limb threatening ischemia ( CLTI) undergoing endovascular revascularization.


Description:

Peripheral arterial disease (PAD) is estimated to affect over 200 million people worldwide. These rates are expected to rise as increasing life expectancies continue to shift the population toward older age. At the most severe end of the disease spectrum, chronic limb-threatening ischemia (CLTI) affects 11% of patients with PAD and is associated with high rates of limb loss and mortality as well as high costs of care.(1) The Society for Vascular Surgery's WIfI (Wound, Ischemia, foot Infection) staging system was developed to classify threatened limbs using factors that affect amputation risk and clinical management in patients with chronic limb threatening ischemia . These include the extent of the wound, degree of ischemia, and severity of any foot infection. It has been validated as a predictor of limb salvage in peripheral artery disease.(2,3) The Global Vascular guidelines 'GVG "proposes a new Global Anatomic Staging System (GLASS), which is a new method of quantifying the anatomic severity of infrainguinal disease in patients with chronic limb-threatening ischemia. But it has not been used for predicting limb salvage apart from use as a tool in deciding the mode of intervention for patients with chronic limb-threatening ischemia (CLTI).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 28
Est. completion date February 1, 2026
Est. primary completion date January 1, 2026
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with CLTI who will undergo endovascular revascularization at our department: • Rutherford stage 4 ( rest pain) ,stage 5 (ischemic ulceration not exceeding ulcer of the digits of the foot) , stage 6 ( severe ischemic ulcers or frank gangrene) Exclusion Criteria: - Rutherford stage 1,2,3 Aortoiliac level of occlusion Unsalvageable limb Patients with contraindications to contrast media Non Atherosclerotic lschemia as • Acute ischemia - Post Traumatic Ischemia - Chronic ischemia caused by connective tissue diseases or vasculitis

Study Design


Related Conditions & MeSH terms

  • Chronic Limb-Threatening Ischemia
  • Ischemia

Intervention

Device:
PTA
Percutaneous Trans lumenal Angioplasty

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (4)

Ananthakumar Murugavel, Ajay Savlania, Arunanshu Behera,Mandeep Kang, Comparison of GLASS Stage with WIfI Clinical Staging for Predicting Limb Salvage in Peripheral Arterial Disease.j.jvs.2023.01.104

Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfe N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S; GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS). Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8. Erratum In: Eur J Vasc Endovasc Surg. 2020 Mar;59(3):492-493. Eur J Vasc Endovasc Surg. 2020 Jul;60(1):158-159. — View Citation

Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G; Society for Vascular Surgery Lower Extremity Guidelines Committee. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34.e1-2. doi: 10.1016/j.jvs.2013.08.003. Epub 2013 Oct 12. — View Citation

Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014 Sep;60(3):686-95.e2. doi: 10.1016/j.jvs.2014.03.290. Epub 2014 May 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Technical Success in - line arterial flow to the foot without any flow limiting dissection or residual stenosis > 30% on completion intraoperative arteriography Baseline
Primary Time to complete healing Time to complete healing of the wound after revascularization, Debridement or minor amputation Baseline
Primary Limb Salvage freedom from major amputation above the foot level Baseline
Primary Primary Patency uninterrupted vessel patency with no procedure performed on the treated limb. Baseline
Primary Assisted Primary Patency the percentage of failing but still patent vessel undergoing elective intervention, included patients required revision of the revascularization before vessel occlusion occurs as prophylactic interventions to maintain patency. Baseline
Primary Secondary Patency an occluded artery that required intervention to restore patency. Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06111599 - Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment N/A
Recruiting NCT05570019 - Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD)
Recruiting NCT06263322 - The ROAMM-EHR Study N/A
Enrolling by invitation NCT06220994 - the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia
Not yet recruiting NCT06404229 - Use of CPETarm for Risk Stratification of Patients With CLTI N/A
Completed NCT05116696 - Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer
Not yet recruiting NCT06264843 - Peripheral Bypass Trial for Completion Control N/A
Not yet recruiting NCT06330493 - AcoArt Litos PCB Below-the-knee Global Trial N/A
Completed NCT03124875 - PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System N/A
Not yet recruiting NCT06149650 - Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Not yet recruiting NCT06186544 - Validating GLASS Score in Predicting Acute Limb Events in CLTI Patients
Not yet recruiting NCT06071429 - Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease N/A
Completed NCT05631444 - Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia Phase 1/Phase 2
Recruiting NCT03622359 - Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease N/A
Active, not recruiting NCT03970538 - PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia N/A
Recruiting NCT05313165 - PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia N/A
Completed NCT04710420 - Prospective Multicenter Registry on the Endovascular Treatment in Critical Limb Threatening Ischemia With Below the Knee Lesions With Wound, Ischemia, and Foot Infection (WIFI) Assessment
Enrolling by invitation NCT06421961 - Agreement Study on AI-assisted Smartphone-based Monitoring Tool for Difficult-to-heal Ischemic Leg Ulcers
Completed NCT05322798 - High-frequency SCS in Treatment of Chronic Limb-Threatening Ischemia N/A
Not yet recruiting NCT06311773 - Pivotal Trial of the Boomerang Catheter for pDVA N/A